Edwards Lifesciences Beats Quarterly Profit Estimates
The medical device maker reported higher earnings today as demand for artificial heart valves grew. Strong sales led the company to raise its annual forecasts.
EDWARDS LIFESCIENCES CORP reported first-quarter financial results that exceeded Wall Street expectations, fueled by sustained demand for its specialized artificial heart valves. The medical technology giant, headquartered in the United States, saw its shares climb more than 4% in after-hours trading following the announcement.
The company is currently benefiting from a broader trend in the healthcare sector where aging populations are increasingly requiring complex cardiac procedures. This demographic shift has led to a significant uptick in the utilization of surgical and procedural devices across the industry.
